<DOC>
	<DOCNO>NCT02854644</DOCNO>
	<brief_summary>This study evaluate frequency spontaneous T cell specific CD4 answer tumoral antigen breast cancer glioma .</brief_summary>
	<brief_title>Study Anti-tumoral Immune Response</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<criteria>Performance status 0,1 2 breast cancer glioma Arm glioma : patient without antitumoral treatment Arm breast cancer : inclusion treatment Arm breast cancer HER2 : patient current therapy Psychiatric disease compromise understanding information realization study vulnerable People accord law ( minor , adult protection , private person freedom ... ) Unaffiliated People Social Security People period exclusion another study Life expectancy estimate unless 3 month . For patient Arm glioma : patient already begin systematic treatment . For patient breast cancer : patient already current therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>